Search research articles
Contact Us
Filters
Showing results (11-20 of 134) with videos related to
Page
of 14
Sort By:
Biotechnology and Bioengineering
|
March 27, 2015
Multiplexed gene transfer to a human T-cell line by combining Sleeping Beauty transposon system with methotrexate selection
Nataly Kacherovsky, Gary W Liu, Michael C Jensen, et al.
Accounts of Chemical Research
|
August 14, 2020
Biomaterials in Chimeric Antigen Receptor T-Cell Process Development
Ian I Cardle, Emmeline L Cheng, Michael C Jensen, et al.
The Journal of Biological Chemistry
|
April 15, 2021
Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting
Ian I Cardle, Michael C Jensen, Suzie H Pun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2010
Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy
Darya Alizadeh, Leying Zhang, Christine E Brown, et al.
Cancer Immunology Research
|
July 3, 2016
ADDENDUM: T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah, Meng-Yin Lin, Anne Silva-Benedict, et al.
Cancer Immunology Research
|
April 10, 2016
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah, Meng-Yin Lin, Anne Silva-Benedict, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme
Jelena Lazovic, Michael C Jensen, Evette Ferkassian, et al.
ACS Nano
|
January 27, 2025
<i>In Situ</i> Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies
Ian I Cardle, Dylan R Scherer, Michael C Jensen, et al.
The Journal of Clinical Investigation
|
December 7, 2007
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger, Michael C Jensen, Peter M Lansdorp, et al.
Molecular Immunology
|
April 17, 2012
Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor
Megan E Prosser, Christine E Brown, Andrew F Shami, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 134) with videos related to
Sort By:
Page
of 14
Biotechnology and Bioengineering
|
March 27, 2015
Multiplexed gene transfer to a human T-cell line by combining Sleeping Beauty transposon system with methotrexate selection
Nataly Kacherovsky, Gary W Liu, Michael C Jensen, et al.
Accounts of Chemical Research
|
August 14, 2020
Biomaterials in Chimeric Antigen Receptor T-Cell Process Development
Ian I Cardle, Emmeline L Cheng, Michael C Jensen, et al.
The Journal of Biological Chemistry
|
April 15, 2021
Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting
Ian I Cardle, Michael C Jensen, Suzie H Pun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2010
Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy
Darya Alizadeh, Leying Zhang, Christine E Brown, et al.
Cancer Immunology Research
|
July 3, 2016
ADDENDUM: T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah, Meng-Yin Lin, Anne Silva-Benedict, et al.
Cancer Immunology Research
|
April 10, 2016
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah, Meng-Yin Lin, Anne Silva-Benedict, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme
Jelena Lazovic, Michael C Jensen, Evette Ferkassian, et al.
ACS Nano
|
January 27, 2025
<i>In Situ</i> Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies
Ian I Cardle, Dylan R Scherer, Michael C Jensen, et al.
The Journal of Clinical Investigation
|
December 7, 2007
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger, Michael C Jensen, Peter M Lansdorp, et al.
Molecular Immunology
|
April 17, 2012
Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor
Megan E Prosser, Christine E Brown, Andrew F Shami, et al.
Page
of 14